- Home
- COMM vs RCUS Comparison
COMM vs RCUS Comparison
Compare COMM & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COMM
- RCUS
- Stock Information
- Founded
- COMM 1976
- RCUS 2015
- Country
- COMM United States
- RCUS United States
- Employees
- COMM N/A
- RCUS N/A
- Industry
- COMM Radio And Television Broadcasting And Communications Equipment
- RCUS Biotechnology: Pharmaceutical Preparations
- Sector
- COMM Technology
- RCUS Health Care
- Exchange
- COMM Nasdaq
- RCUS Nasdaq
- Market Cap
- COMM 1.1B
- RCUS 1.2B
- IPO Year
- COMM 2013
- RCUS 2018
- Fundamental
- Price
- COMM $5.37
- RCUS $7.71
- Analyst Decision
- COMM Hold
- RCUS Strong Buy
- Analyst Count
- COMM 4
- RCUS 10
- Target Price
- COMM $3.50
- RCUS $29.50
- AVG Volume (30 Days)
- COMM 5.5M
- RCUS 905.1K
- Earning Date
- COMM 05-08-2025
- RCUS 05-07-2025
- Dividend Yield
- COMM N/A
- RCUS N/A
- EPS Growth
- COMM N/A
- RCUS N/A
- EPS
- COMM N/A
- RCUS N/A
- Revenue
- COMM $4,205,800,000.00
- RCUS $258,000,000.00
- Revenue This Year
- COMM $21.62
- RCUS N/A
- Revenue Next Year
- COMM $8.76
- RCUS $25.77
- P/E Ratio
- COMM N/A
- RCUS N/A
- Revenue Growth
- COMM N/A
- RCUS 120.51
- 52 Week Low
- COMM $0.86
- RCUS $7.51
- 52 Week High
- COMM $7.19
- RCUS $18.98
- Technical
- Relative Strength Index (RSI)
- COMM 48.99
- RCUS 26.87
- Support Level
- COMM $5.05
- RCUS $8.02
- Resistance Level
- COMM $5.95
- RCUS $8.57
- Average True Range (ATR)
- COMM 0.26
- RCUS 0.43
- MACD
- COMM -0.01
- RCUS -0.02
- Stochastic Oscillator
- COMM 53.60
- RCUS 8.35
About COMM CommScope Holding Company Inc.
CommScope Holding Co Inc is a provider of infrastructure solutions for communication, data center and entertainment networks. The company provides solutions for wired and wireless networks to enable service providers, including cable, telephone, data center and digital broadcast satellite operators and media programmers, to deliver media, voice, Internet Protocol (IP) data services and Wi-Fi to their subscribers and allow enterprises to experience constant wireless and wired connectivity across complex and varied networking environments. They have operating segments, which excludes our Home segment: Connectivity and Cable Solutions (CCS), Outdoor Wireless Networks (OWN), Networking, Intelligent Cellular and Security Solutions (NICS) and Access Network Solutions (ANS).
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.